Constellation Biomarker Review
Judge an intervention through a portfolio of health measures
- Difficulty
- Advanced
- Time to result
- ~months to results
- Steps
- 6
- Confidence
- 86%
The Constellation Biomarker Review evaluates an intervention against a portfolio of objective measures instead of one convenient target. A clinician starts with the patient's whole health context, selects relevant organ-function, inflammation, aging, or other validated markers, and records a baseline. The intervention then sits within the complete treatment regimen rather than being credited for every later change. After an appropriate interval, the same measures are reviewed as a pattern: improvement, deterioration, mixed movement, or no meaningful change. This mechanism helps resist the weak inference that raising NAD—or any single intermediate marker—is itself a sufficient clinical endpoint. Dr Daran Shah outlined the approach in response to a practitioner asking how he tests whether treatment is working. The framework requires qualified interpretation and does not establish that the episode's promoted product causes better outcomes.
Origin
During audience questions, Dr Daran Shah answered a challenge about endpoints by describing his use of a constellation of laboratory measures.
Core principles
- 01A single changed marker is not a complete endpoint
- 02Measure the wider health system before interpreting an intervention
- 03Track objective changes over time
- 04Treat an intervention as one part of a broader regimen
How to run it
- 1
Frame the health question
Define what meaningful improvement would look like for the patient beyond a change in the intervention's immediate target.
Pro tip Separate clinical outcomes from intermediate biomarkers before testing begins.
Watch out Do not choose endpoints after seeing the results.
- 2
Build the measure set
Select a relevant constellation of validated laboratory and clinical measures rather than relying on one number.
Pro tip Include measures capable of detecting harm as well as hoped-for benefit.
Watch out More tests are not automatically more informative.
- 3
Capture the baseline
Measure the chosen indicators before changing the regimen so later comparisons have a defensible reference point.
Watch out An absent or inconsistent baseline weakens causal interpretation.
- 4
Document the full regimen
Record the intervention alongside other treatments and behaviour changes that could influence the same measures.
Pro tip Minimize simultaneous changes when clinically appropriate and safe.
Watch out Do not attribute every movement to the featured intervention.
- 5
Repeat and compare
Re-test at a clinically appropriate interval and compare the whole pattern with the baseline.
Pro tip Use the same measurement conditions where practical.
- 6
Decide from the pattern
Continue, adjust, or stop based on the combined evidence and the patient's clinical context.
Pro tip Label mixed evidence as mixed rather than forcing a positive verdict.
Watch out Biomarkers require qualified clinical interpretation.
In the wild
A clinician records baseline organ-function and inflammatory measures before adding one component to a wider regimen. At follow-up, one target marker rises but inflammation and the patient's reported function do not improve. Rather than calling the intervention successful, the clinician classifies the evidence as mixed and reviews the plan.
→ The decision reflects the full pattern instead of one favourable number.
Common mistakes
Using the target as the outcome
Showing that an intervention changes its immediate target does not by itself show that the patient's health improved.
Changing everything together
Multiple simultaneous additions make it difficult to know which change influenced the follow-up pattern.
Cherry-picking one favourable marker
Ignoring neutral or worsening measures defeats the purpose of evaluating a constellation.
Is it for you?
Best for
It is best for qualified clinicians monitoring multi-part health regimens over time.
Not ideal for
It is not ideal for self-diagnosis, casual consumer experimentation, or situations without valid outcome measures.
From the transcript
“we do comprehensive lab testing on patients we check uh all different organ function inflammatory markers um biological age”
“I take it as a constellation of different lab tests which indicate a patient's overall health”
“track objectively their health status through Improvement in various different biomarkers”
From the episode
Episode 304: The Longevity Secret Everyone's Talking About: NAD+ Exposed with Expert Panel!